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Abstract
Context: Premenstrual syndrome (PMS) is a common but still poorly understood cyclical disorder of 
women in the reproductive age. Prevalence figures vary widely reflecting differences in modes of 
assessment and population sampled. It has been found to be more common and severe among well 
educated women with a possible association with stress. The female student population of Ambrose Alli 
Uuniversity, Ekpoma thus typifies a population at risk of this disorder. 
Objective: To determine the prevalence, pattern and severity of PMS as well as perception and 
treatment seeking behaviour of the study population.
Methods: This was a descriptive cross-sectional survey conducted among female undergraduates of 
Ambrose Alli University, Ekpoma, Edo State, in order to assess the prevalence and severity of symptoms 
of the premenstrual syndrome (PMS) among them.  Four hundred and four (404) respondents selected 
using the cluster sampling technique completed self-administered questionnaires distributed to them.  
Results: PMS diagnosed using the ICD  10 criteria, was found in 94.8% of the study group.  The common 
symptoms were abdominal pain/discomfort, breast pain/swelling, fatigue, irritability and decreased 
interest in usual activities.  The least frequent symptoms were crying spells and suicide ideation.  
Analgesics were the most commonly used form of remedy (48.8%) while only one respondent (0.3%) 
used the oral contraceptive pill specifically as a remedy for PMS.  There was a statistically significant 
association between severity of symptoms and treatment   between the age of respondents and use of 
oral contraceptive pills with severity of symptoms.  
Conclusion: PMS is a very common but poorly understood condition in our environment.  More local 
studies are advocated on this subject as well as increased public enlightenment to enhance the effective 
management of this condition.  
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Introduction complete absence of symptoms in the 
6Premenstrual Syndrome (PMS) is a common postmenstrum' . Sutherland and Stewart define 
cyclical disorder of young women which has it as “any combination of emotional or physical 
psychological, behavioural and physical signs and symptoms that occur cyclically prior to 
components and may seriously affect a woman's menstruation and regress or disappear during or 
7health. This disorder though extensively after menstruation” . PMS is defined by the 
researched has continued to present difficulties National Institute of Mental Health as “the cyclic 
with regards to definition, aetiology, diagnosis occurrence of symptoms that are of sufficient 
1, 2, 3
and efficacy of treatment . severity to interfere with some aspects of life and 
which appear with consistent and predictable 
8The first published description of this syndrome relationship to menses” . Multiple definitions 
4
as the “premenstrual tension” was by Frank  in 
1931 but the term “premenstrual syndrome” 
5was first used in 1953 by Greene and Dalton . 
Various definitions of this condition abound in 
the literature. Dalton defined PMS as 'the 
recurrence of symptoms in the premenstrum but 
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2notwithstanding, there is a general acceptance B- endorphin though their role is less defined . 
of the fact that this condition is recurrent and Attempts to link vitamin and mineral deficiencies 
20, 21
to PMS/PMDD have been inconclusive . cyclical, occurring in the luteal phase and of 
Prevalence studies on PMS have revealed a wide sufficient severity as to interfere with work, 
9, 10, 11, 12
relationship and lifestyle . range, reflecting differences in modes of 
assessment and population sampled. Some 
6reported prevalence figures are 15-100% , 40-The severe form of PMS was defined and 
11 1, 20operationalized by the American  Psychiatric 95% , and 75% . On the African continent, a 
Association.  It was initially termed the Late prevalence of 95.5% was reported among nurses 
22Luteal Phase Dysphoric Disorder (LLPDD) in the in Nairobi  and 99.6% among university students 
233rd edition of the Diagnostic and Statistical in Ethiopia . Prevalence studies on PMS have 
 13 24 Manual of Mental Disorders (DSM-III-R)  and been very few in Nigeria. Antai et al reported a 
 14later included in the 4th edition (DSM-IV)  as the prevalence of 85.5% among university 
Premenstrual Dysphoric Disorder (PMDD). undergraduates in Calabar, while Fakeye and 
25Adegoke  found severe PMS in about 20% of 
The aetiology of the symptom complex of PMS is post menarcheal secondary school girls in Ilorin. 
not known although several theories have been The prevalence of PMDD is 3-8%, with the 
proposed including oestrogenprogesterone vulnerable years being the late 20's and early 
i m b a l a n c e ,  h y p e r p r o l a c t i n a e m i a ,  30's. Since its first description, a large 
hypoglycaemia, excess aldosterone and constellation of symptoms (over 150) have been 
1, 15psychogenic factors . It appears that natural related to the PMS, most of which are non-
ovarian cyclicity is a prerequisite for PMS and this specific and immeasurable by objective 
is supported by the efficacy of ovarian cyclicity standards. Some of the symptoms of PMS 
suppression either medically, or surgically, in actually represent physiologic and behavioural 
16, 17, 18causing resolution of symptoms .  Gonadal changes associated with a normal menstrual 
hormones are thought to influence the activity of cycle.
neurotransmitters especially serotonin. 
Generally, decreased levels of gonadal hormones Symptoms like breast tenderness, bloating, 
are associated with decreased serotoninergic mood changes and lower abdominal cramps are 
2  
components of the premenstrual molimina, activity .  Central serotonin levels are typically 
which characterize ovulatory cycles. PMS may low in women with PMS/PMDD and many 
well be a severe form of this normal physiologic women report benefiting from Selective 
23, 26, 27 1,2,19 pattern .  Serotonin Reuptake Inhibitors (SSRIs) .Other 
neurotransmitters implicated include GABA and 
Making the diagnosis of PMS has been demonstrated a beneficial effect with some of 
problematic since its specific aetiology is these remedies, reports on others have been 
1, 2, 20, 29unknown and there is no objective marker to conflicting .  
quantify the existence or severity of 
symptomatology, as well as objective response The psychosocial components of this disorder as 
to therapy. In the WHO International well as inherent diagnostic problems make 
28Classification of Diseases, 10th Edition (ICD-10) , denial, misdiagnosis and poor treatment quite 
PMS is listed as a physical disorder and there is no common.  Most women with PMS are able to 
requirement for a minimum number of perform their day-to-day activities.  However, in 
symptoms or functional Impairment to make a its severe form, this disorder has been associated 
diagnosis of PMS. PMDD as a diagnosis using the with increased absenteeism from school and 
DSM-IV criteria has an identical physical work, poor academic performance, high suicide 
30, 31symptom list with PMS. However, more rates and increased crime rate .  Studies have 
emphasis is placed on the emotional and indicated that PMS is more common and more 
behavioural symptoms, which are significantly severe among well educated women than 
more serious with PMDD and go far beyond what uneducated women with a possible association 
32,33are considered manageable or normal of PMS with stress . Ambrose Alli University, 
premenstrual symptoms. Ekpoma, with a large number of female students 
in their 20's and 30's, exemplifies a population 
Treatment of PMS aims to relieve symptoms and particularly at risk of premenstrual syndrome.       
restore function, and often requires a 
combination of lifestyle modification and drug This study seeks to determine the prevalence of 
therapy. Frequently used remedies include oral PMS among female undergraduates of Ambrose 
contraceptives, serotonin reuptake inhibitors, Alli University, Ekpoma; document the pattern 
antidepressants, anxiolytics, progesterone, and severity of the symptoms, the perception of 
diuretics, vitamins B  and E, calcium, magnesium this condition, as well as treatment seeking 6
and herbal products. Exercise, eating smaller, behaviour of the affected population.  This will 
more frequent meals and reducing consumption result in better understanding of this condition in 
of sugar, salt, caffeine and alcohol are also our environment and enable health care 
1, 2, 20advocated .Efficacy of these treatment providers manage affected patients more 
m o d a l i t i es  va r y,  w h i l e  s t u d ies  h ave  satisfactorily.
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 respectively), while the faculties of Agriculture 
Materials and Methods and Engineering had the least number of 
This was a descriptive cross sectional survey respondents (1.5% each).
conducted at the Ambrose Alli University, 
Ekopoma.  The university is located in Ekpoma, The age of the study population ranged between 
Esan Local Government Area of Edo State, 16 and 33 years with a mean age of 22.9  3.4 
Nigeria, with a female undergraduate student years.  More than half (57.7%) of the study 
population of 4,826. A sample size of 370 female participants were aged between 20 and 24 years 
undergraduates was picked based on the while only 7 (1.7%) were aged 30 years and 
nformula: nf = / / . Where: nf = the desired above as shown in Table 1.  Majority were single 1+ (n) (N)
(94.1%), nulliparous (95.5%) and Christians sample size when the population is less than 10, 
(98.5%).  In addition, mean age at menarche was 000, n = the desired sample size when the 
13.8  0.65 years with a range of 10-20 years. population is more than 10,000 (400), N = the 
About 90.6% had a normal menstrual cycle estimated population size (4, 826). Four hundred 
length between 21 and 35 days and 97.8% had a and fifty (450) Questionnaires were prepared to 
normal duration between 2 and 8 days.  Only 48 compensate for anticipated non-response and 
(11.9%) were using oral contraceptive pills as a respondents were selected using the cluster 
method of family planning.  sampling technique. A pre-tested, structured 
self-administered questionnaire was employed 
Of the 404 respondents whose questionnaires for data collection.  This contained variables such 
were analysed, 11(2.7%) had no premenstrual as demographic characteristics and gynaecologic 
symptom, 10(2.5%) had premenstrual  history of respondents.  It also included 
symptoms which persisted beyond one week of questions pertaining to the presence, extent and 
the follicular phase of the menstrual cycle and severity of known premenstrual symptoms 
could therefore not be classified as true PMS.  experienced regularly over the past 6 menstrual 
Premenstrual syndrome diagnosed using the cycles.  Premenstrual syndrome was diagnosed 
ICD-10 criteria, was found in 383 respondents, using the WHO-ICD 10 criteria.  Perception, 
giving a prevalence of 94.8%.treatment-seeking behaviour and remedy usage 
among respondents were also assessed. Data 
Table 2 shows the frequency of various was analysed using Microsoft excel and EPI-info 
symptoms of PMS among the study participants.  2004 software packages.  Significance of 
The most common symptoms were Abdominal associations was determined using the chi-
pain or discomfort affecting 375 (75.5%), breast square test, a p-value <0.05 was taken as being 
pain or swelling in 236(58.4%), fatigue in significant.
175(43.3%), irritability affecting 173 (42.8%), 
and decreased interest in usual activities Results: 
affecting 167 (41.3%). The least common A total of 450 questionnaires were distributed.  
symptoms were oedema/weight gain in 86 Thirty (30) questionnaires could not be retrieved, 
(21.3%), crying spells in 57 (14.1%) and suicide 16 questionnaires were inadequately completed 
ideation in 22 (5.4%).and were excluded, leaving a total of 404 
questionnaires (89.8%) for analysis. The 404 
Table 3 is a classification of the severity of respondents were distributed among nine 
premenstrual symptoms based on subjective faculties of the University.  The Social Science 
reporting by the respondents who had PMS. One and Natural Science faculties had the highest 
hundred and ninety (49.6%) reported their number of respondents (28.5% and 22.5% 
symptoms as mild, having little or no effect on and their treatment seeking behaviour as well as 
their usual activities, 143(37.3%) and 27(7.1%) remedy usage. Two hundred and twenty five 
had moderate  and severe  symptoms (67.6 %) of those with mild/moderate symptoms 
respectively, while 23(6.0%) reported their and twenty five (50.0%) of those with 
symptoms as extreme, hindering participation in severe/extreme symptoms did not seek 
any activity. Table 4 summarizes respondents' treatment.  On the other hand, 50.0% (25) of 
perception of PMS, their treatment seeking those with severe/extreme symptoms and 32 %( 
behaviour as well as use of various remedies for 108) of those with mild/moderate symptoms 
the treatment of this condition.  Only 67 sought treatment.  This difference was 
respondents with PMS (17.5%) considered it to statistically significant (p = 0.023). Also, 48.3% 
be an illness while 316(82.5%) viewed the (161) of those with mild/moderate symptoms 
condition as a normal part of womanhood. One did not use any form of remedy while only 22.0% 
hundred and thirty three (34.7%) had specifically (11) of those with severe / extreme symptoms 
sought treatment for PMS, and 211 (55.1%) failed to use any remedy. Thirty nine (78.0%) of 
admitted using one form of remedy or the other those with severe/extreme symptoms used at 
for the condition. Seventy eight (20.4%) least one form of remedy compared with 172 
consulted the patent medicine dispenser (51.7%) of those with mid/moderate symptoms 
(“chemist”) while 55 (14.3%) went to the who did same.
hospital.
Table 6 tests the significance of association 
Analgesics (NSAIDS, paracetamol, dipyrone) and between the age of respondents, usage of oral 
the antispasmodic-Hyoscine, were the most contraceptive pills (OCP) and severity of their 
commonly used remedies by 187 (48.8%) and 42 symptoms.  Two hundred and twenty nine (68.8 
(11.0%) respondents respectively.  Less %) respondents with mild/moderate symptoms 
commonly used remedies were herbs in 3(0.8%), were less than 25 years old, and so were 68.0% 
Antibiotics in 2 (0.5%) and the oral contraceptive (34) of those with severe/extreme symptoms.  
pill (OCP) which was used specifically as a remedy Moreover,  32.0% (16)  of  those with 
for PMS (and not primarily for contraception) by severe/extreme symptoms were 25 years and 
only 1  respondent (0.3%) . 0ne hundred and above but this was also the case with 31.2% (104) 
ninety four (50.7%) claimed subjective relief of of those with mild/moderate symptoms. There 
symptoms after using these remedies was no statistically significant difference 
Table 5 tests the significance of association between these two age groups (p=0.957). The 
between severity of symptoms of respondents study also showed that 11.4% (38) of those with 
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Majority (86.9%) of the 383 respondents with mild/moderate symptoms had been using oral 
PMS considered their symptoms as mild or contraceptive pills (primarily for contraception) 
moderate while only 50 (13.1%) reported their but this also applied to 12.0% (6) of those with 
symptoms as severe or extreme.  This prevalence severe/extreme symptoms.  Moreover, 88.0% 
figure of 13.1% for severe/extreme PMS is much (44) of those with severe / extreme symptoms 
higher than the often reported PMDD were not using OCPs but this was also the case 
2, 20
prevalence rate of 3-8% .  It must be noted with 88.6 (295) of those with mild/moderate 
however that the latter figures are based on symptoms.  There was no statistically significant 
studies in the general population unlike this difference between the two groups (p = 0.908). 
study conducted among University students who 
are at high risk of developing severe PMS Discussion
possibly because of associated stress, as has The study reveals a premenstrual syndrome 
23,32,33
been reported from other studies . (PMS) prevalence of 94.8% among female 
Moreover, an accurate diagnosis of PMDD using undergraduates of Ambrose Alli University, 
the DSM  IV criteria requires prospective Ekpoma.  This is comparable with the prevalence 
21 charting of symptoms, which was not the study of 95.5% reported from Nairobi  and 99.6% 
22 design in this case.  reported from Ethiopia  but higher than the 
23
85.5% prevalence reported by Antai et al  
Less than a quarter (17.5%) of the respondents among female undergraduates of the University 
with PMS considered it to be an illness and the of Calabar.  Prevalence rates up to 95% have 
6, 7, 11, 34 majority (82.5%) perceived PMS as a normal part been reported in many other studies .  The 
22
of womanhood.  Rupani and Lema  reported high prevalence of PMS in this study population 
similar findings among nurses in Nairobi.  The may be related to the high level of stress faced by 
general perception of PMS in this environment University students.  Their educational status 
may influence the subjective reporting of also makes recall of symptoms easier in this 
severity of symptoms by affected respondents as group.  Such factors have been highlighted in 
23, 32, 33 well as their treatment-seeking-behaviour.  Only some studies . 
about a third (34.7%) specifically sought 
treatment for this condition though more than A b d o m i n a l  p a i n / d i s c o m f o r t ,  b r e a s t  
half (55.1%) admitted using one form of remedy pain/swelling, fatigue, irritability and decreased 
or the other for treating PMS.  Majority of those interest in usual activities were the commonest 
who sought treatment consulted the patent symptoms of PMS and were all reported by over 
medicine dispenser (“chemist”) rather than 40% of respondents.  These symptoms have also 
22, going to the hospital.  This is the general trend of been commonly reported in other studies
23,24,35,36 consultations for ailments in our society where .  Oedema/weight gain, change in appetite 
people are reluctant to go to the hospital due to and abdominal bloating were however not 
financial constraints, and would rather opt for prominent symptoms in this study compared 
cheaper avenues of treatment or go on self-with some of these earlier reports.  Suicide 
medication. Such practice however denies ideation was the least common symptom, 
patients access to expert medical advice and affecting only 5.4% of respondents.  It was also 
22, 23 optimal treatment.         found to be a rare symptom in similar studies .
Analgesics, in particular the Non-steroidal anti- Some other studies did not find any correlation 
22, 35inflammatory drugs (NSAIDS) were the most between age and PMS either .  Severe 
commonly used form of remedy.  This may be PMS/PMD is said to be more common in the late 
1, 2, 20re l a ted  to  t h e  fa c t  t h at  a b d o m i n a l  twenties and mid-thirties .  Such association 
pain/discomfort and mastalgia were the most was not obtained in this study probably because 
common symptoms in the study group.  of the relatively few students aged 25 and above 
Moreover, NSAIDS and antispasmodics like in the study population (124/404, 30.6%) with a 
hysoscine (Buscopan) are popular drugs for the mean age of 22.9 years.  Variations in study 
treatment of dysmenorrhoea and that may also population have been said to affect the 
influence their choice as medications for PMS.  assessment of such relationships. 
Similar findings have been reported by Addis et 
23 37
al  and Singh et al . There was also no significant relationship 
between oral contraceptive use and severity of 
23Only 1 respondent (0.3%) used the oral symptoms (P>0.05).  Addis et al  reported 
contraceptive pill (OCP) specifically as a form of similar findings.  The very low level of OCP 
remedy for PMS and not primarily for utilization as contraceptive in the study group 
contraception.  This is probably because oral (48/404, 11.9%) may have affected this result.  
contraceptive use is generally perceived solely as Moreover, while oral contraceptives have 
a family planning method without other benefit in the treatment of dysmenorrhoea, 
benefits. Notably too, non-pharmacological their efficacy in the treatment of PMS is yet to be 
remedies like dietary modifications, aerobic substantiated, with some women even reporting 
1, 2, 20, 29exercise, stress management and cognitive exacerbation of symptoms with OCP usage .  
behavioural therapy were not employed by any Conclusion: PMS was found to be a very common 
of the affected respondents. Moreover, condition in this study with a prevalence of 
serotoninergic antidepressants, now considered 94.8%, yet is a seldom discussed topic, even 
to be the first line treatment for emotional and among medical experts in this country.  This no 
1, 2,12,15,20
affective premenstrual symptoms , were doubt contributes to the paucity of information 
not prescribed to, or used by any respondent.  All on the subject among the general populace as 
these findings reflect the gross paucity of well as the obvious knowledge deficit in the 
information on this subject, not only in the management of this condition. More prevalence 
general population but even among health care studies on PMS especially using prospective 
providers as well. methods  are  recommended.   Pub l i c  
enlightenment programmes on this condition is 
The study shows a statistically significant also advocated in order to bridge the information 
relationship between severity of symptoms and gap on the subject matter in our society. This will 
treatment-seeking behaviour as well as remedy lead to a better understanding of a condition 
usage among affected respondents (P<0.05).  which may significantly impair the quality of life 
23Addis et al  reported similar results.  of women in the reproductive age group and also 
There was no significant difference in severity of has potential medico-legal implications. 
symptoms between those less than 25 years old 
and respondents aged 25 and above (P>0.05).  
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